Olivier Feron

Olivier Feron

Université Catholique de Louvain

H-index: 87

Europe-Belgium

About Olivier Feron

Olivier Feron, With an exceptional h-index of 87 and a recent h-index of 50 (since 2020), a distinguished researcher at Université Catholique de Louvain, specializes in the field of cancer, metabolism, hypoxia, acidosis, translational research.

His recent articles reflect a diverse array of research interests and contributions to the field:

Tumoral acidosis promotes adipose tissue depletion by fostering adipocyte lipolysis

Phospholipase PLA2G7 is complementary to GPX4 in mitigating punicic acid induced ferroptosis in prostate cancer cells

A novel approach to pH-Responsive targeted cancer Therapy: Inhibition of FaDu cancer cell proliferation with a pH low insertion Peptide-Conjugated DGAT1 inhibitor

Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to ATM and ATR inhibitors

Cent scientifiques répliquent à SEA (Suppression des Expériences sur l’Animal vivant) et dénoncent sa désinformation

Targeting glucose metabolism in cancer immunity and immunotherapy

Targeting M2 macrophages with a novel NADPH oxidase inhibitor

Deciphering the interplay between circadian rhythms and metabolic preferences in colorectal cancer cells and 3D spheroids.

Olivier Feron Information

University

Université Catholique de Louvain

Position

___

Citations(all)

45106

Citations(since 2020)

17501

Cited By

37415

hIndex(all)

87

hIndex(since 2020)

50

i10Index(all)

255

i10Index(since 2020)

177

Email

University Profile Page

Université Catholique de Louvain

Olivier Feron Skills & Research Interests

cancer

metabolism

hypoxia

acidosis

translational research

Top articles of Olivier Feron

Title

Journal

Author(s)

Publication Date

Tumoral acidosis promotes adipose tissue depletion by fostering adipocyte lipolysis

Molecular metabolism

Camille Lefevre

Morgane M Thibaut

Audrey Loumaye

Jean-Paul Thissen

Audrey M Neyrinck

...

2024/5/1

Phospholipase PLA2G7 is complementary to GPX4 in mitigating punicic acid induced ferroptosis in prostate cancer cells

iScience

Perrine Vermonden

Manon Martin

Katarzyna Glowacka

Ineke Neefs

Josef Ecker

...

2024/4/18

A novel approach to pH-Responsive targeted cancer Therapy: Inhibition of FaDu cancer cell proliferation with a pH low insertion Peptide-Conjugated DGAT1 inhibitor

International Journal of Pharmaceutics

Marine Deskeuvre

Junjie Lan

Joris Messens

Olivier Riant

Olivier Feron

...

2024/4/17

Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to ATM and ATR inhibitors

EMBO reports

Léo Aubert

Estelle Bastien

Ophélie Renoult

Céline Guilbaud

Kübra Özkan

...

2024/2/16

Cent scientifiques répliquent à SEA (Suppression des Expériences sur l’Animal vivant) et dénoncent sa désinformation

La Libre Belgique

Agnès Burniat

Agnès Noël

Alain Colige

Alain Vanderplasschen

Alban de Kerchove d'Exaerde

...

2023/4/3

Targeting glucose metabolism in cancer immunity and immunotherapy

Frontiers in Immunology

Olivier Feron

Chih-Hao Chang

Frédérique Végran

2023/3/8

Targeting M2 macrophages with a novel NADPH oxidase inhibitor

Antioxidants

Sébastien Dilly

Miguel Romero

Stéphanie Solier

Olivier Feron

Chantal Dessy

...

2023/2/10

Deciphering the interplay between circadian rhythms and metabolic preferences in colorectal cancer cells and 3D spheroids.

Léo Aubert

Kübra Özkan

Sarah Srhir

Philippine Bruno

Céline Guilbaud

...

2023

Resistance to CLnA-induced ferroptosis is acquired in Caco-2 cells upon differentiation

Frontiers in Cell Death

Géraldine Cuvelier

Perrine Vermonden

Justine Rousseau

Olivier Feron

René Rezsohazy

...

2023

Tandem Heck/Tsuji-Trost Reaction for Uncaging of Alloc-Protected Amines with Palladium Complexes in Living Cells

Journal of Organometallic Chemistry

Yonghua Tan

Marine Lefevre

François Pierrard

Mathieu Soetens

Maria Shoueiry

...

2023/9/1

Ex vivo purging of cancer cells from ovarian tissue using photodynamic therapy: a novel strategy to restore fertility in leukemia patients

Human reproduction open

Saeid Moghassemi

Arezoo Dadashzadeh

Alessandra Camboni

Olivier Feron

Ricardo Bentes Azevedo

...

2023/1/1

Hypoxia regulates acetylation/deacetylation of non-histone proteins through PLIN2 and SCD1 expression in cancer cells.

Coline Wery

Adrien Godfroid

Géraldine Luis

Agnès Noël

Olivier Feron

...

2022/6/22

The impact of macrophages on endothelial cells is potentiated by cycling hypoxia: Enhanced tumor inflammation and metastasis

Frontiers in oncology

Victor Delprat

Camille Huart

Olivier Feron

Fabrice Soncin

Carine Michiels

2022/9/28

Photodynamic therapy using OR141-loaded nanovesicles for eradication of leukemic cells from ovarian tissue

Photodiagnosis and photodynamic therapy

Saeid Moghassemi

Arezoo Dadashzadeh

Alessandra Camboni

Olivier Feron

Ricardo Bentes Azevedo

...

2022/12/1

Inhibition of basal and glucagon-induced hepatic glucose production by 991 and other pharmacological AMPK activators

Biochemical Journal

Manuel Johanns

Cyril Corbet

Roxane Jacobs

Melissa Drappier

Guido T Bommer

...

2022/6/22

Hypoxia regulates non-histone proteins acetylation through PLIN2 and SCD1 in cancer cells.

Coline Wery

Géraldine Luis

Adrien Godfroid

Agnès Noël

Olivier Feron

...

2022/9/6

Discovery of mitochondrial complex I inhibitors as anticancer and radiosensitizer drugs based on compensatory stimulation of lactate release

Cancers

Junjie Lan

Octavia Cadassou

Cyril Corbet

Olivier Riant

Olivier Feron

2022/11/6

Non-histone protein acetylation/deacetylation are regulated by PLIN2 and SCD1 during cancer cells adaptation to hypoxia.

Coline Wery

Adrien Godfroid

Géraldine Luis

Agnès Noël

Olivier Feron

...

2022/4/8

Targeting cancer cells in acidosis with conjugates between the carnitine palmitoyltransferase 1 inhibitor etomoxir and pH (low) insertion peptides

International Journal of Pharmaceutics

Marine Deskeuvre

Junjie Lan

Emeline Dierge

Joris Messens

Olivier Riant

...

2022/8/25

Insights in pharmacology of anti‐cancer drugs: 2021

Frontiers in pharmacology

Patricia Sancho

Olivier Feron

2022/10/21

See List of Professors in Olivier Feron University(Université Catholique de Louvain)

Olivier Feron FAQs

What is Olivier Feron's h-index at Université Catholique de Louvain?

The h-index of Olivier Feron has been 50 since 2020 and 87 in total.

What are Olivier Feron's top articles?

The articles with the titles of

Tumoral acidosis promotes adipose tissue depletion by fostering adipocyte lipolysis

Phospholipase PLA2G7 is complementary to GPX4 in mitigating punicic acid induced ferroptosis in prostate cancer cells

A novel approach to pH-Responsive targeted cancer Therapy: Inhibition of FaDu cancer cell proliferation with a pH low insertion Peptide-Conjugated DGAT1 inhibitor

Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to ATM and ATR inhibitors

Cent scientifiques répliquent à SEA (Suppression des Expériences sur l’Animal vivant) et dénoncent sa désinformation

Targeting glucose metabolism in cancer immunity and immunotherapy

Targeting M2 macrophages with a novel NADPH oxidase inhibitor

Deciphering the interplay between circadian rhythms and metabolic preferences in colorectal cancer cells and 3D spheroids.

...

are the top articles of Olivier Feron at Université Catholique de Louvain.

What are Olivier Feron's research interests?

The research interests of Olivier Feron are: cancer, metabolism, hypoxia, acidosis, translational research

What is Olivier Feron's total number of citations?

Olivier Feron has 45,106 citations in total.